Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Publication of Peer-Reviewed Article in Food and Chemical Toxicology Journal

Business Wire September 7, 2022

Avivagen (TSXV:VIV) secures new customer in Mexico

Trevor Abes  August 19, 2022

Avivagen Announces New Dairy Customer in Mexico

Business Wire August 19, 2022

Avivagen Announces Receipt of Repeat Order from Asian Customer

Business Wire August 11, 2022

Avivagen Announces Significant Order of OxC-beta(TM)  in Brazil

Business Wire August 3, 2022

Avivagen (TSXV:VIV) announces sales of companion animal product and management change

Azuka Onwuka July 29, 2022

Avivagen Announces Sales of Companion Animal Product and Management Change

Business Wire July 29, 2022

Avivagen Inc. Announces Closing of Third Tranche of a Private Placement of Shares and Warrants

Business Wire July 6, 2022

Avivagen Inc. Announces Options Grant

Business Wire June 20, 2022

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2022

Business Wire June 15, 2022

Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene (OxBC)

Business Wire June 9, 2022

Avivagen Provides Second Update on Non-Brokered Private Placement

Business Wire June 3, 2022

Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares and Warrants for Proceeds of Up to $5.0 Million

Business Wire May 31, 2022

Avivagen (TSXV:VIV) signs agreement with Vietnamese feed distributor

Caroline Egan  May 30, 2022

Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth

Business Wire May 30, 2022

Avivagen Announces Approval in China, the World's Largest Commercial Feed Production Market

Business Wire May 12, 2022

Avivagen Provides Update on Non-Brokered Private Placement

Business Wire May 6, 2022

Avivagen Inc. Announces Closing of First Tranche of a Private Placement of Shares and Warrants for Proceeds of up to $5.0 Million

Business Wire April 28, 2022

Avivagen Announces AGM Results and Update to Shareholders

Business Wire April 8, 2022

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2022

Business Wire March 30, 2022